Moody Aldrich Partners LLC lifted its position in SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 4.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 171,748 shares of the company’s stock after acquiring an additional 6,823 shares during the period. Moody […]
By Rob Curran Shares of SI-Bone rose after the medical-device maker received clearance from the Food and Drug Administration to market its bone-implant.
Lisanti Capital Growth LLC lessened its stake in SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 42.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 34,330 shares of the company’s stock after selling 25,725 shares during the period. Lisanti Capital Growth […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 1,470 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $20.92, for a total transaction of $30,752.40. Following the completion of the sale, the chief financial officer now directly owns 147,268 […]